SCHEMBL6868346

SCHEMBL6868346

CN(C)c1nc(N[C@H]2CC[C@@H](NC(=O)Nc3cccc(Oc4ccccc4)c3)CC2)nc2c1CCCC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
EPHX1 P07099 1/20 0.45
MCHR1 Q99705 13/20 0.44
ADRA2A P08913 12/20 0.44
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ADRA1A P35348 2/20 0.41
HRH1 P35367 2/20 0.41
HTR2B P41595 2/20 0.41
HTR1A P08908 1/20 0.41
NPY5R Q15761 1/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
PPARG P37231 1/20 0.40
HTT P42858 1/20 0.40
NCOA2 Q15596 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6868351 1.00 USP30 (0.46) USP30NPC1RAB9AEPHX1MCHR1
SCHEMBL6874492 0.92 EPHX1 (0.54) NPC1RAB9AEPHX1MCHR1ADRA2A
SCHEMBL6874485 0.92 EPHX1 (0.54) NPC1RAB9AEPHX1MCHR1ADRA2A
SCHEMBL6876368 0.91 NPC1 (0.57) NPC1RAB9AMCHR1ADRA2AMAPT
SCHEMBL6876374 0.91 NPC1 (0.57) NPC1RAB9AMCHR1ADRA2AMAPT
SCHEMBL6867234 0.87 MCHR1 (0.43) EPHX1MCHR1ADRA2AADRA1AHRH1
SCHEMBL6867239 0.87 MCHR1 (0.43) EPHX1MCHR1ADRA2AADRA1AHRH1
SCHEMBL6877130 0.87 EPHX2 (0.47) NPC1RAB9AEPHX1MCHR1ADRA2A
SCHEMBL6877125 0.87 EPHX2 (0.47) NPC1RAB9AEPHX1MCHR1ADRA2A
SCHEMBL7109740 0.87 NPC1 (0.54) NPC1RAB9AMCHR1ADRA2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed